These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7105642)

  • 21. Effects of epomediol on ethinyloestradiol-induced changes in glutathione homeostasis in the rat.
    Cuevas MJ; Almar M; González-Gallego J
    Pharmacol Toxicol; 2002 Mar; 90(3):121-6. PubMed ID: 12071332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahepatic cholestasis in acute viral hepatitis: a double-blind trial with dihydroxydibutylether in comparison with placebo.
    Marchettini G; Corsini P; Massimini G
    Drugs Exp Clin Res; 1987; 13(1):51-6. PubMed ID: 3297594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Functional dyspeptic syndrome caused by dyskinesia of the bile ducts. Auscultatory percussion diagnosis and therapeutic monitoring].
    Stagnaro Neri M; Stagnaro S
    Clin Ter; 1988 Dec; 127(5):363-72. PubMed ID: 2976634
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Insights on Intrahepatic Cholestasis of Pregnancy.
    Floreani A; Gervasi MT
    Clin Liver Dis; 2016 Feb; 20(1):177-89. PubMed ID: 26593298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
    Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
    Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
    [No Abstract]   [Full Text] [Related]  

  • 27. Liver: a variant of FGF19 protects the liver from cholestatic injury without inducing cancer.
    Patman G
    Nat Rev Gastroenterol Hepatol; 2014 Oct; 11(10):579. PubMed ID: 25134510
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrahepatic cholestasis and eclampsia: a case report.
    Atabey S; Duvan CI; Eren U; Turhan NO
    Hypertens Pregnancy; 2007; 26(4):363-9. PubMed ID: 18066956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cholestasis: therapeutic options].
    Beuers U; Oswald M
    Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged cholestasis due to hepatitis A virus infection.
    Kumar P; Bhatia V
    Indian Pediatr; 2011 Jun; 48(6):485-6. PubMed ID: 21743116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the plasma clearance of antipyrine after treatment of healthy male volunteers with epomediol.
    Del Vecchio S; Ulissi A; Tavanti A; Delle Monache M; Munoz ME; Ventura P; Schiavi A; Ricci GL
    J Hepatol; 1990 Nov; 11(3):390-1. PubMed ID: 2290033
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical study of an original synthetic choleretic: 3,4-methylenedioxycinnamic acid].
    Tacca GP
    Minerva Gastroenterol; 1974; 20(4):168-74. PubMed ID: 4459733
    [No Abstract]   [Full Text] [Related]  

  • 34. Intrahepatic cholestasis of pregnancy: a case report.
    Konjeti R; Selsky N
    Conn Med; 2012 Mar; 76(3):163-4. PubMed ID: 22666977
    [No Abstract]   [Full Text] [Related]  

  • 35. Protective effect of epomediol on calcium release induced by palmitoyl CoA in the sarcoplasmic reticulum.
    Bindoli A; Cavallini L; Siliprandi N
    Pharmacol Res Commun; 1984 Jul; 16(7):647-52. PubMed ID: 6473484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)].
    Masmoudi A; Hadj-Taieb I; Kammon T; Mseddi M; Boudaya S; Chaabouni M; Hachicha M; Turki H
    Ann Dermatol Venereol; 2008 Mar; 135(3):228-30. PubMed ID: 18374858
    [No Abstract]   [Full Text] [Related]  

  • 37. Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans.
    Duttala S; Tobi M; Dingell JD
    Gastroenterology; 2006 Feb; 130(2):619-20; author reply 620. PubMed ID: 16472623
    [No Abstract]   [Full Text] [Related]  

  • 38. Capillary gas chromatographic determination of epomediol in human plasma and urine using a rapid solid-phase extraction.
    Girometta MA; Loschi L; Ventura P; Canali S; Giachetti C; Zanolo G
    Biomed Chromatogr; 1989 Sep; 3(5):199-202. PubMed ID: 2804425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of biliary epomediol-beta-glucuronide levels with bile flow enhancement in the rat.
    Ventura P; Lumachi B; Luzzani F; Scuri R
    Arzneimittelforschung; 1985; 35(10):1548-9. PubMed ID: 4074413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biotransformation of epomediol. I--Isolation and identification of main metabolites in the rat.
    Ventura P; Selva A
    Biomed Mass Spectrom; 1982 Jan; 9(1):18-21. PubMed ID: 7059659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.